About: Koronis Pharmaceuticals

An Entity of Type: agent, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Koronis Pharmaceuticals is a Seattle area biotechnology company founded in 1998. Koronis is dedicated to the development of antiviral therapeutics based on a novel mechanism, Viral Decay Acceleration (VDA). The Company's lead product candidate is KP-1461 for the treatment of human immunodeficiency virus (HIV) infection. The company also has products in development for the treatment of hepatitis C and RSV infection.

Property	Value
dbo:abstract	Koronis Pharmaceuticals is a Seattle area biotechnology company founded in 1998. Koronis is dedicated to the development of antiviral therapeutics based on a novel mechanism, Viral Decay Acceleration (VDA). The Company's lead product candidate is KP-1461 for the treatment of human immunodeficiency virus (HIV) infection. The company also has products in development for the treatment of hepatitis C and RSV infection. (en)
dbo:foundingYear	1998-01-01 (xsd:gYear)
dbo:industry	dbr:Biotechnology
dbo:thumbnail	wiki-commons:Special:FilePath/KP-1461.svg?width=300
dbo:wikiPageExternalLink	https://www.reuters.com/article/us-koronis-hiv-idUSTRE72C1AX20110313 https://www.reuters.com/article/us-koronis-hiv/u-s-hiv-drug-firm-koronis-looks-to-london-listing-idUSTRE72C1AX20110313 https://www.seattlepi.com/business/article/Biotech-pioneer-Gillis-ventures-into-a-new-field-1179674.php https://www.seattlepi.com/news/article/Koronis-HIV-drug-draws-funding-1242160.php http://www.koronispharma.com https://www.forbes.com/forbes/2011/0808/focus-hiv-biotech-koronis-pandemic-drug-embracing-enemy.html%231afb122d73df https://www.popsci.com/node/205298
dbo:wikiPageID	20519274 (xsd:integer)
dbo:wikiPageLength	2824 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1044711698 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Antiviral_drug dbr:Reuters dbc:Biotechnology_companies_of_the_United_States dbc:Companies_based_in_Seattle dbr:Error_catastrophe dbr:The_New_Yorker dbr:Forbes dbr:KP-1461 dbr:HIV/AIDS dbr:Hepatitis_C dbr:Biotechnology dbr:Popular_Science dbr:Seattle dbr:Human_respiratory_syncytial_virus dbr:Seattle_P-I dbr:File:KP-1461.svg
dbp:industry	dbr:Biotechnology
dbp:wikiPageUsesTemplate	dbt:Citation dbt:Infobox_company dbt:No_footnotes dbt:Refbegin dbt:Refend dbt:Start_date_and_age dbt:Med-company-stub
dcterms:subject	dbc:Biotechnology_companies_of_the_United_States dbc:Companies_based_in_Seattle
gold:hypernym	dbr:Company
rdf:type	owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 yago:WikicatBiotechnologyCompaniesOfTheUnitedStates yago:WikicatCompaniesBasedInSeattle,Washington yago:Abstraction100002137 yago:Company108058098 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Organisation yago:SocialGroup107950920
rdfs:comment	Koronis Pharmaceuticals is a Seattle area biotechnology company founded in 1998. Koronis is dedicated to the development of antiviral therapeutics based on a novel mechanism, Viral Decay Acceleration (VDA). The Company's lead product candidate is KP-1461 for the treatment of human immunodeficiency virus (HIV) infection. The company also has products in development for the treatment of hepatitis C and RSV infection. (en)
rdfs:label	Koronis Pharmaceuticals (en)
owl:sameAs	freebase:Koronis Pharmaceuticals yago-res:Koronis Pharmaceuticals wikidata:Koronis Pharmaceuticals https://global.dbpedia.org/id/4pQyi
prov:wasDerivedFrom	wikipedia-en:Koronis_Pharmaceuticals?oldid=1044711698&ns=0
foaf:depiction	wiki-commons:Special:FilePath/KP-1461.svg
foaf:isPrimaryTopicOf	wikipedia-en:Koronis_Pharmaceuticals
is dbo:wikiPageDisambiguates of	dbr:Koronis
is dbo:wikiPageWikiLink of	dbr:Koronis
is foaf:primaryTopic of	wikipedia-en:Koronis_Pharmaceuticals